EVOTEC EXPANDS IPSC DRUG DISCOVERY LEADERSHIP THROUGH STRATEGIC COLLABORATION WITH CENSO BIOTECHNOLOGIES

My account

Cart

Checkout

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a collaboration with Censo Biotechnologies Ltd. (“Censo”) to source and provide patient-derived induced pluripotent stem cells (“iPSC”) to support Evotec’s broad iPSC platform.

Censo will provide its sourcing and reprogramming technologies and expertise to create a high-quality, bespoke repository of hundreds of patient-derived iPS cell lines, covering multiple diseases with an initial focus on CNS diseases. The contract will run for an initial period of two years.

Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: “We are very pleased to have teamed up with Censo, a proven leader in the field of iPSCs – covering in particular the sourcing of donor cells, the generation of iPS cell lines as well as extensive characterisation and quality control. Their platform will support and complement Evotec’s use of patient-derived disease models for drug screening and the discovery of more disease-relevant drug candidates.”

Aidan Courtney, CEO of Censo Biotechnologies, noted: “Both Censo and Evotec believe in the enabling power of patient-derived iPSCs as a drug discovery tool. This collaboration is a validation of Censo’s extensive network, technology platform and expertise in this space. We look forward to working closely with our colleagues at Evotec and supporting their ambitious plans for iPSC-based drug discovery.”

No financial details were disclosed.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.